Bidirectional Pharmacology of GIP Receptor Targeting in Obesity: Historical Foundations, Mechanistic Divergence, and Translational Boundaries

Related

• Cell Metabolism·8 Oct 2026

  A triple-target drug cut body weight by up to 19.7% in a trial

  

• JCI Insight·6 Oct 2026

  Antibody reduced fat while preserving lean mass in mice

  

• Diabetes, Obesity & Metabolism·4 Oct 2026

  Genetically proxied GIP pathway links to lower fracture risk

• The New England Journal of Medicine·4 Oct 2026

  Retatrutide reduces weight and pain in adults with obesity